文献速递肾移植

澳大利亚肾移植等待名单患者动态、暂停、移植与死亡

Journey to kidney transplantation: patient dynamics, suspensions, transplantation and deaths in the Australian kidney transplant waitlist.
PubMed 文献 · Nephrol Dial Transplant · 2024-01-01

37%患者至少被暂停一次,暂停者预测等待移植时间3.0年 vs 未暂停者1.9年,当前暂停时等待死亡风险增加12倍。

要点

  • 37%等待名单患者至少被暂停一次,暂停者移植等待时间平均延长1年
  • 当前暂停状态使等待期死亡风险增加12倍(95%CI 8.0-18.3)
  • 既往暂停使再次暂停风险增加4.2倍,移植可能性降低29%

核心结论

  • 等待名单旅程不简单,暂停常见且影响移植机会,平均延长等待1年。
  • 提供了暂停、重新入列及结局的估计与相关因素以支持知情讨论。

研究设计与样本

  • 描述等待名单后所有临床转归,用限制性平均生存时间预测首次移植时间,用灵活生存模型和Cox模型评估相关因素。

主要发现

  • 6741例(80%)接受移植,381例(5%)等待中死亡,1344例(16%)仍在等待。
  • 3127例(37%)至少被暂停一次。
  • 暂停者预测等待至移植时间3.0年(95%CI 2.8-3.2),未暂停者1.9年(95%CI 1.8-1.9)。
  • 既往暂停使再次暂停可能性增加4.2倍(95%CI 3.8-4.6),重返等待名单增加50%(95%CI 36-65),移植可能性降低29%(95%CI 62-82)。
  • 当前暂停时等待死亡风险增加12倍(95%CI 8.0-18.3)。

临床怎么用

  • 向等待名单患者告知暂停对移植等待时间和死亡风险的影响。
  • 关注暂停高风险患者,减少可避免的暂停以改善移植可及性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: People on the kidney waitlist are less informed about potential suspensions. Disparities may exist among those who are suspended and who return to the waitlist. We evaluated the patient journey after entering the waitlist, including suspensions and outcomes, and factors associated with these transitions. METHODS: We included all incident patients waitlisted for their first transplant from deceased donors in Australia from 2006 to 2019. We described all clinical transitions after entering the waitlist. We predicted the restricted mean survival time (unadjusted and adjusted) until first transplant by the number of prior suspensions. We evaluated factors associated with transitions using flexible survival models and clinical endpoints using Cox models. RESULTS: Of 8466 patients waitlisted and followed over 45 757.4 person-years (median 4.8 years), 6741 (80%) were transplanted, 381 (5%) died waiting and 1344 (16%) were still waiting. A total of 3127 (37%) people were suspended at least once. Predicted mean time from waitlist to transplant was 3.0 years [95% confidence interval (CI) 2.8-3.2] when suspended versus 1.9 years (95% CI 1.8-1.9) when never suspended. Prior suspension increased the likelihood of further suspensions 4.2-fold (95% CI 3.8-4.6) and returning to the waitlist by 50% (95% CI 36-65) but decreased the likelihood of transplantation by 29% (95% CI 62-82). Death risk while waiting was increased 12-fold (95% CI 8.0-18.3) when currently suspended. Australian non-Indigenous males were 13% [hazard ratio (HR) 1.13 (95% CI 1.04-1.23)] and Asian males 23% [HR 1.23 (95% CI 1.06-1.42)] more likely to return to the waitlist compared with females of the same ethnicity. CONCLUSION: The waitlist journey was not straightforward. Suspension was common, impacted the chance of transplantation and meant waiting an average of 1 year longer until transplant. We have provided estimates for and factors associated with suspension, relisting and outcomes after waitlisting to support more informed discussions. This evidence is critical to further understand drivers of inequitable access to transplantation.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. De La Mata NL, Khou V, Hedley JA, et al. Journey to kidney transplantation: patient dynamics, suspensions, transplantation and deaths in the Australian kidney transplant waitlist. Nephrol Dial Transplant. 2024. PMID: 38017628. doi:10.1093/ndt/gfad253

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。